Cytogenetic Abnormalities Correlate with the Plasma Cell Labeling Index and Extent of Bone Marrow Involvement in Myeloma
- 1 August 1999
- journal article
- Published by Elsevier BV in Cancer Genetics and Cytogenetics
- Vol. 113 (1), 73-77
- https://doi.org/10.1016/s0165-4608(99)00009-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants.Journal of Clinical Oncology, 1997
- Multiple MyelomaNew England Journal of Medicine, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Diagnostic and Prognostic Significance of Cytogenetics in Adult Primary Myelodysplastic SyndromesLeukemia & Lymphoma, 1996
- Cytogenetic findings in 200 patients with multiple myelomaCancer Genetics and Cytogenetics, 1995
- Cancer cytogenetics for cliniciansCA: A Cancer Journal for Clinicians, 1994
- Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma [see comments]Blood, 1993
- Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies.Journal of Clinical Oncology, 1988
- Culturing and robotic harvesting of bone marrow, lymph nodes, peripheral blood, fibroblasts, and solid tumors with in situ techniquesCancer Genetics and Cytogenetics, 1988